Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
STX-1911
- Development stage
- Preclinical
- Lead developer
- Solu Therapeutics
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous
01
Overview
STX-1911 is a bispecific Cytotoxicity Targeting Chimera (CyTAC) in development by Solu Therapeutics for the treatment of prostate cancer. Developed using Solu's proprietary CyTAC platform, STX-1911 is designed to target and eliminate prostate cancer cells by recognizing two tumor antigens highly expressed in prostate cancer. The therapeutic construct utilizes a heterobifunctional small molecule linked to a proprietary antibody-drug conjugate (ADC) platform antibody, combining the precise target-binding capabilities of small molecules with the effector functions and pharmacokinetic profile of a biologic. STX-1911 is currently in the discovery stage of development.
Beyond the preview
Go deeper on STX-1911.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STX-1911.